Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for Lower Extremity Blocks in ACL Repair
NCT01756560Phase 4
Key facts
- Status
- Terminated
- Start
- Jan 2013
- Primary completion
- Jan 2015
- Countries
- 1
- Sponsor
- University of Chicago
- Modality
- Orthosteric Ligands
- Drugs
- dexamethasone
- Conditions
- postoperative pain
01
Overview
Phase 4, randomised, double-blind trial of dexamethasone in postoperative pain (2 arms), sponsored by University of Chicago. Primary endpoint: Analgesia Duration at 72 hours. Started Jan 2013; status: terminated.
02
Design
2 arms- Study design
- RandomizedDouble-blind
Control Arm
Plain bupivacaine for femoral and sciatic nerve block.
Dexamethasone Arm
Bupivacaine mixed with dexamethasone for femoral and sciatic nerve block.
03
Who it enrols
Adults aged 18-75 undergoing ACL repair with no contraindications to regional anesthesia and no history of peripheral neuropathy.
04
Endpoints
Primary
Analgesia Duration
Beyond the preview
Go deeper on NCT01756560.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01756560.